May 7, 2025 06:09PM
May 7, 2025 04:05PM
Mar 25, 2025 04:48PM
Mar 25, 2025 04:05PM
Feb 6, 2025 04:10PM
Feb 6, 2025 07:04AM
Feb 6, 2025 07:03AM 2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
Nov 12, 2024 07:04AM
Nov 12, 2024 07:00AM
Nov 4, 2024 04:01PM
Aug 7, 2024 07:10AM
Aug 7, 2024 07:00AM
Aug 5, 2024 07:00AM
May 8, 2024 07:10AM 2seventy bio, Inc. (TSVT) Misses Q1 EPS by 26c
May 8, 2024 07:00AM
May 3, 2024 07:00AM
Apr 5, 2024 09:06AM
Apr 5, 2024 09:05AM
Mar 20, 2024 05:04PM
Mar 20, 2024 05:04PM
Mar 15, 2024 06:27PM FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
Mar 5, 2024 07:04AM
Mar 5, 2024 07:00AM
Mar 1, 2024 07:00AM
Feb 5, 2024 07:02AM
Feb 5, 2024 06:59AM
Dec 12, 2023 03:22AM
Dec 11, 2023 07:30PM Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3
Nov 20, 2023 07:00AM
Nov 20, 2023 06:59AM
Nov 14, 2023 07:04AM
Nov 14, 2023 07:00AM
Nov 10, 2023 07:00AM
Sep 13, 2023 07:58AM
Sep 12, 2023 07:02AM 2seventy bio (TSVT) Announces Strategic Restructuring, CEO to Step Down
Sep 12, 2023 07:00AM
Aug 14, 2023 03:51PM
Aug 14, 2023 07:00AM
Aug 8, 2023 07:00AM
May 11, 2023 12:37PM
May 3, 2023 04:05PM
May 1, 2023 07:05AM 2seventy bio (TSVT) and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15M Preclinical Milestone
May 1, 2023 07:00AM
Apr 28, 2023 08:30AM
Apr 27, 2023 06:59AM
Apr 17, 2023 07:09AM
Apr 17, 2023 06:59AM
Mar 29, 2023 01:30AM
Mar 16, 2023 04:05PM 2seventy bio Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Progress
Feb 10, 2023 11:15AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All